Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Rank in Stocks #2092
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Share Price
$141.47
Market Cap
$9.81B
Change (1 day)
0.26%
Change (1 year)
-55.60%
Country
US
Trade Insulet Corp. (PODD)

Category

Healthcare
Stock split history for Insulet Corp. (PODD)
Insulet Corp. stock (symbol: PODD) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 19, 2026.
One PODD share bought prior to Oct 19, 2026 would equal to 0 PODD shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE